Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8490183rdf:typepubmed:Citationlld:pubmed
pubmed-article:8490183lifeskim:mentionsumls-concept:C0031307lld:lifeskim
pubmed-article:8490183lifeskim:mentionsumls-concept:C0078058lld:lifeskim
pubmed-article:8490183lifeskim:mentionsumls-concept:C0148199lld:lifeskim
pubmed-article:8490183lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:8490183lifeskim:mentionsumls-concept:C1513475lld:lifeskim
pubmed-article:8490183pubmed:issue10lld:pubmed
pubmed-article:8490183pubmed:dateCreated1993-6-11lld:pubmed
pubmed-article:8490183pubmed:abstractTextVascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is a polypeptide mediator, elaborated by certain tumors and other cell types, that exerts multiple effects on endothelium via interaction with a class of high-affinity binding sites. In this report, the interaction of VPF/VEGF with human mononuclear phagocytes (MPs) is characterized. Radioligand binding studies at 4 degrees C showed the presence of a single class of binding sites, kd approximately 300 to 500 pmol/L (approximately 20 times lower affinity than the high-affinity binding site on endothelial cells [ECs]), the occupancy of which correlated with VPF/VEGF-induced MP migration and expression of tissue factor. These binding results were paralleled by functional experiments which indicated that the same VPF/VEGF preparations were about an order of magnitude less effective in stimulating MP chemotaxis than in inducing EC proliferation. When MPs with surface-bound 125I-VPF/VEGF were warmed to 37 degrees C, endocytosis and degradation occurred. Occupancy of VPF/VEGF binding site resulted in subsequent activation of intracellular signal transduction mechanisms, as shown by an increase in MP intracellular calcium concentration. Cross-linking studies with 125I-VPF/VEGF showed a new high-molecular weight band (corresponding to putative 125I-VPF/VEGF-receptor complex), the appearance of which was blocked by excess unlabeled VPF/VEGF. Consistent with these results, immunoprecipitation of 32PO4-labeled MPs exposed to VPF/VEGF showed a single band of similar mobility, not seen in untreated controls. These results demonstrate that the interaction of VPF/VEGF with MPs, though of lower affinity than that observed with ECs, also results from interaction of the polypeptide with a specific cell-surface protein and leads to activation of intracellular transduction mechanisms.lld:pubmed
pubmed-article:8490183pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:languageenglld:pubmed
pubmed-article:8490183pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8490183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8490183pubmed:statusMEDLINElld:pubmed
pubmed-article:8490183pubmed:monthMaylld:pubmed
pubmed-article:8490183pubmed:issn0006-4971lld:pubmed
pubmed-article:8490183pubmed:authorpubmed-author:REESW HWHlld:pubmed
pubmed-article:8490183pubmed:authorpubmed-author:SterzHHlld:pubmed
pubmed-article:8490183pubmed:authorpubmed-author:KanKKlld:pubmed
pubmed-article:8490183pubmed:authorpubmed-author:ShenHHlld:pubmed
pubmed-article:8490183pubmed:authorpubmed-author:SchmidtA MAMlld:pubmed
pubmed-article:8490183pubmed:authorpubmed-author:ConnollyDDlld:pubmed
pubmed-article:8490183pubmed:authorpubmed-author:ClaussMMlld:pubmed
pubmed-article:8490183pubmed:authorpubmed-author:BordetJJlld:pubmed
pubmed-article:8490183pubmed:authorpubmed-author:TijburgPPlld:pubmed
pubmed-article:8490183pubmed:issnTypePrintlld:pubmed
pubmed-article:8490183pubmed:day15lld:pubmed
pubmed-article:8490183pubmed:volume81lld:pubmed
pubmed-article:8490183pubmed:ownerNLMlld:pubmed
pubmed-article:8490183pubmed:authorsCompleteYlld:pubmed
pubmed-article:8490183pubmed:pagination2767-73lld:pubmed
pubmed-article:8490183pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:meshHeadingpubmed-meshheading:8490183-...lld:pubmed
pubmed-article:8490183pubmed:year1993lld:pubmed
pubmed-article:8490183pubmed:articleTitleCharacterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.lld:pubmed
pubmed-article:8490183pubmed:affiliationDepartment of Physiology, Columbia University-College of Physicians and Surgeons, New York, NY 10032.lld:pubmed
pubmed-article:8490183pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8490183pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8490183pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8490183lld:pubmed